When tumor cells from the Luminal-A breast cancer subtype were exposed to TME-enriched conditions consisting of TNFα and endothelial growth factor (EGF), the breast cancer cell population became enriched for a CD44+CD29+ CSC phenotype with increased metastatic properties [83]. This evidence concerns the gene CD44 and breast carcinoma.